Biotech News Recap: Acer Therapeutics' Long-Term Data Supports Approval [Seeking Alpha]
Acer Therapeutics Inc. (ACER)
Last acer therapeutics inc. earnings: 3/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
acertx.com/investor-relations
Company Research
Source: Seeking Alpha
Biotech News Recap: Acer Therapeutics' Long-Term Data Supports Approval Summary Aquestive Therapeutics announced FDA acceptance of NDA for riluzole oral film in ALS. Acer Therapeutics' announced publication of long-term data from a cohort of COL3A1-positive vEDS patients is in the Journal of the American College of Cardiology. Mesoblast announced that the FDA has agreed to rolling BLA submission for remestemcel-L in children with steroid-refractory acute Graft Versus Host Disease. BioDelivery Sciences' recent in-licensing of Symproic (naldemedine) US rights should boost long-term growth prospects and diversify its commercial portfolio. Ophthotech continues its transition to being a gene therapy concern with a name change to IVERIC bio. Acer Therapeutics ( ACER publication of long-term data Survival was 80.7% for patients treated with celiprolol versus 48.5% in those not treated after 11.1 years of follow-up. AQST Mesoblast ( MESO BioDelivery Sciences ( BDSI announced licensing of US r
Show less
Read more
Impact Snapshot
Event Time:
ACER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACER alerts
High impacting Acer Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics